Amyloid beta (A4) Precursor Protein (APP) (Middle Region) Peptide
Aperçu rapide pour Amyloid beta (A4) Precursor Protein (APP) (Middle Region) Peptide (ABIN973339)
Antigène
Origine
Source
Application
-
-
Protein Region
- Middle Region
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-APP antibody (Catalog #: ARP33074_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- APP (Amyloid beta (A4) Precursor Protein (APP))
-
Sujet
-
APP is a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for this gene.This gene encodes a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for this gene.
Alias Symbols: AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN2, PN-II
Protein Interaction Partner: NAE1,TGFB1,TGFB2,APBA1,APP,HTRA2,PSEN1,PSEN1,PSEN1,PSEN2,APBA1,MAPK8IP1,PSEN1,PSEN1,ABL1,ACHE,APBA1,APBA2,APBA3,APBB1,APBB2,APBB3,APOE,APPBP2,BACE1,BACE2,BCAP31,BGN,BLMH,CALR,CASP3,CASP4,CASP6,CASP8,CAV1,CDK5,CHRNA7,CLU,COL1A2,COL25A1,COL4A1,COL4A2,COL4A3,COL4A5,COL4A6,CRYAB,CTSD,DAB1,EPB41,F12,FBLN1,FLOT1,GAPDH,GPC1,GRB2,GSK3B,GSN,HADHB,HMOX2,HSD17B10,HSPG2,HTRA2,IDE,ITM2B,KAT5,KLC1,KNG1,LAMA1,LDLRAP1,LRP1,LRP1B,MAPK8IP1,MAPK8IP2,NAE1,NCSTN,NECAB3,NF1,NID1,NUMB,NUMBL,PIN1,PPID,PRSS2,PRSS3,PSEN1,PSEN2,SERPINA3,SHC1,SHC3,SNCA,SNCB,SPON1,TGFB1,TGFB2,TM2D1,TP53BP2,ACHE,APBA1,APBA2,APBA3,APBB1,APBB2,APBB3,APPBP2,Apbb1,Apbb1,BGN,BLMH,CALR,CAV1,CLSTN1,COL25A1,DAB1,DAB2,FBLN1,GSN,HGS,HSD17B10,KLC1,NAE1,NCSTN,SHC1,SNCA,SNCB
Protein Size: 695 -
Poids moléculaire
- 77 kDa
-
ID gène
- 351
-
NCBI Accession
- NM_201414, NP_958817
-
UniProt
- P05067
Antigène
-